000 01638 a2200469 4500
005 20250518071031.0
264 0 _c20201023
008 202010s 0 0 eng d
022 _a1471-2369
024 7 _a10.1186/s12882-019-1595-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAthavale, Ambarish
245 0 0 _aDesmopressin and bleeding risk after percutaneous kidney biopsy.
_h[electronic resource]
260 _bBMC nephrology
_c11 2019
300 _a413 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAngiography
_xmethods
650 0 4 _aBiopsy
_xadverse effects
650 0 4 _aBlood Coagulation
_xdrug effects
650 0 4 _aCreatinine
_xblood
650 0 4 _aDeamino Arginine Vasopressin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHemostasis, Surgical
_xstatistics & numerical data
650 0 4 _aHemostatics
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKidney
_xblood supply
650 0 4 _aKidney Diseases
_xdiagnosis
650 0 4 _aKidney Function Tests
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOutcome and Process Assessment, Health Care
650 0 4 _aPatient Selection
650 0 4 _aPostoperative Hemorrhage
_xblood
650 0 4 _aRetrospective Studies
650 0 4 _aUltrasonography
_xmethods
650 0 4 _aUnited States
_xepidemiology
700 1 _aKulkarni, Hemant
700 1 _aArslan, Cagil D
700 1 _aHart, Peter
773 0 _tBMC nephrology
_gvol. 20
_gno. 1
_gp. 413
856 4 0 _uhttps://doi.org/10.1186/s12882-019-1595-4
_zAvailable from publisher's website
999 _c30316093
_d30316093